Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

about

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

Item

http://www.wikidata.org/entity/Q48306335

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@en

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@nl

type

Item

label

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@en

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@nl

prefLabel

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@en

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@nl

P1476

Oncophosphosignaling Favors a Glycolytic Phenotype in Human Drug Resistant Leukemia.

@en

P2093

Alessandra V S Faria

http://www.w3.org/2001/XMLSchema#string

Carmen V Ferreira-Halder

http://www.w3.org/2001/XMLSchema#string

Emanuella M B Fonseca

http://www.w3.org/2001/XMLSchema#string

Karin J P Rocha-Brito

http://www.w3.org/2001/XMLSchema#string

Karla C S Queiroz

http://www.w3.org/2001/XMLSchema#string

Leonardo R Silveira

http://www.w3.org/2001/XMLSchema#string

Renato Milani

http://www.w3.org/2001/XMLSchema#string

Tamira O Santos

http://www.w3.org/2001/XMLSchema#string

Thaís F Tornatore

http://www.w3.org/2001/XMLSchema#string

P2860

Management of Chronic Myeloid Leukemia Patients Resistant to Tyrosine Kinase Inhibitors Treatment

Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase

Mitochondria and cancer

Multidrug resistance in tumour cells: characterization of the multidrug resistant cell line K562-Lucena 1.

Tyr-301 phosphorylation inhibits pyruvate dehydrogenase by blocking substrate binding and promotes the Warburg effect.

Knocking down low molecular weight protein tyrosine phosphatase (LMW-PTP) reverts chemoresistance through inactivation of Src and Bcr-Abl proteins.

The Warburg Effect: How Does it Benefit Cancer Cells?

ATP/ADP ratio, the missed connection between mitochondria and the Warburg effect.

Low molecular weight protein tyrosine phosphatase (LMWPTP) upregulation mediates malignant potential in colorectal cancer.

The role of autophagy in cancer development and response to therapy.

P304

3846-3854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.26034

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Maikel P Peppelenbosch

Igor H Sampaio

P577

2017-04-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28387439

http://www.w3.org/2001/XMLSchema#string